Molina Healthcare Inc (NYSE:MOH)

$ 292.18 -2 (-0.68%) Market Cap: 16.83 Bil Enterprise Value: 10.14 Bil PE Ratio: 14.94 PB Ratio: 3.52 GF Score: 89/100

Q3 2024 Molina Healthcare Inc Earnings Call Transcript
Oct 24, 2024

$323.59 (+17.67%)

Earnings
Q2 2024 Molina Healthcare Inc Earnings Call Transcript
Jul 25, 2024

$324.17 (+12.28%)

Earnings
Q1 2024 Molina Healthcare Inc Earnings Call Transcript
Apr 25, 2024

$352.3 (-4.11%)

Earnings
Q4 2023 Molina Healthcare Inc Earnings Call Transcript
Feb 08, 2024

$381.49 (+5.35%)

Earnings
Q3 2023 Molina Healthcare Inc Earnings Call Transcript
Oct 26, 2023

$331.39 (-1.50%)

Earnings
Q2 2023 Molina Healthcare Inc Earnings Call Transcript
Jul 27, 2023

$307.34 (-1.23%)

Earnings
Molina Healthcare Inc To Host Investor Day Transcript
May 15, 2023
Q1 2023 Molina Healthcare Inc Earnings Call Transcript
Apr 27, 2023

$296.92 (+7.75%)

Earnings
Q4 2022 Molina Healthcare Inc Earnings Call Transcript
Feb 09, 2023

$301.33 (-1.90%)

Earnings
Molina Healthcare Inc To Update Investors On Medi-Cal Contracts Call Transcript
Jan 03, 2023
Q3 2022 Molina Healthcare Inc Earnings Call Transcript
Oct 27, 2022

$351.79 (-4.72%)

Earnings
Q2 2022 Molina Healthcare Inc Earnings Call Transcript
Jul 28, 2022

$317.09 (+3.68%)

Earnings
Q1 2022 Molina Healthcare Inc Earnings Call Transcript
Apr 28, 2022

$315.38 (-2.61%)

Earnings
Q4 2021 Molina Healthcare Inc Earnings Call Transcript
Feb 10, 2022

$306.16 (-0.41%)

Earnings
Q3 2021 Molina Healthcare Inc Earnings Call Transcript
Oct 28, 2021

$297.14 (+0.51%)

Earnings
Molina Healthcare Inc Virtual Investor Day Transcript
Sep 17, 2021
Q2 2021 Molina Healthcare Inc Earnings Call Transcript
Jul 29, 2021

$255.21 (-1.53%)

Earnings
Molina Healthcare Inc Annual Shareholders Meeting Transcript
May 06, 2021
Q1 2021 Molina Healthcare Inc Earnings Call Transcript
Apr 29, 2021

$253.77 (+2.06%)

Earnings
Q4 2020 Molina Healthcare Inc Earnings Call Transcript
Feb 11, 2021

$216.26 (+4.88%)

Earnings
Molina Healthcare Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
Q3 2020 Molina Healthcare Inc Earnings Call Transcript
Oct 29, 2020

$187.11 (-3.17%)

Earnings
Q2 2020 Molina Healthcare Inc Earnings Call Transcript
Jul 31, 2020

$184.7 (-1.24%)

Earnings
Evolent Health Inc Agreement Between Molina Healthcare And Passport Health Plan For Molina To Acquire Certain Assets Of Passport Call Transcript
Jul 17, 2020
Molina Healthcare Inc Annual Shareholders Meeting Transcript
May 07, 2020
Magellan Health Inc and Molina Healthcare Inc Enter Into Definitive Agreements to Divest Magellan Complete Care - Conference Call Transcript
May 01, 2020
Q1 2020 Molina Healthcare Inc Earnings and Definitive Agreement to Acquire Magellan Complete Care Call Transcript
May 01, 2020
Q4 2019 Molina Healthcare Inc Earnings Call Transcript
Feb 11, 2020

$141.42 (+9.33%)

Earnings
Molina Healthcare Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Q3 2019 Molina Healthcare Inc Earnings Call Transcript
Oct 30, 2019

$123.88 (-0.64%)

Earnings
Q2 2019 Molina Healthcare Inc Earnings Call Transcript
Jul 31, 2019

$132.78 (-3.43%)

Earnings
Molina Healthcare Inc Investor Day Meeting Transcript
May 30, 2019
Q1 2019 Molina Healthcare Inc Earnings Call Transcript
Apr 30, 2019

$129.63 (+0.70%)

Earnings
Q4 2018 Molina Healthcare Inc Earnings Call Transcript
Feb 12, 2019

$129.39 (-5.62%)

Earnings

Molina Healthcare Inc To Update Investors On Medi-Cal Contracts Call Transcript

Jan 03, 2023 / 01:00PM GMT

Release Date Price: $318.92 (-3.42%)

Transcript

Operator

Good day, and welcome to the Molina Healthcare Conference Call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Joe Krocheski, Senior Vice President of Investor Relations. Please go ahead.

Joseph F. Krocheski

Molina Healthcare, Inc. - SVP of IR

Good morning, and welcome to Molina Healthcare's call to discuss updates to our California Medi-Cal Contract Awards. Joining me today are Molina's President and CEO, Joe Zubretsky; and our CFO, Mark Keim.

During our call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our California Medi-Cal Awards, our projected revenue and earnings growth associated with these awards, as now modified, and our overall financial outlook with regard to both fiscal year 2023 and 2024. Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that can cause our actual results to differ materially from our current expectations. We advise listeners to

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.